Abstract:Background When employing the transcription-mediated amplification method for screening blood donors, there are some non-discriminatory reactive results which are screening assay reactive but HBV-DNA discriminatory assay negative. This raises concerns regarding the possibility of false positives among donors, which may lead to permanent deferral of blood donors and affect blood supply. This study aimed to elucidate the infection status of these non-discriminatory reactive blood donors and develop and validate a model to predict individualized hepatitis B status to establish an optimal screening strategy. Methods Supplementary tests were conducted on initial non-discriminating reactive donations to determine their HBV infection status, including repeat testing, viral load, serological marker detection, and follow-up. Primary clinical variables of the donors were recorded. Based on the Akaike information criterion, a stepwise forward algorithm was used to identify the predictive factors for information and construct a predictive model. The optimal screening strategy was determined through cost-effectiveness analysis. Results At the Blood Center of Zhejiang Province, 435 cases of initial non-discriminatory reactive donations were collected over two successive periods and sub-categorized through repeated testing into the following three groups: non-repeated positive group, non-discriminated positive group, and non-repeated HBV-DNA positive group. The HBV discriminatory rate increased after repeated testing (110/435, 25.29%). According to supplementary tests, the HBV-DNA positivity rate was 65.52% (285/435), and occult HBV infection was a significantly different among groups (χ 2 = 93.22, p < 0.01). The HBV serological markers and viral load in the non-repeated positive group differed from those in the other two groups, with a lower viral load and a higher proportion of false positives. The predictive model constructed using a stepwise forward algorithm exhibited high discrimination, good fit, high calibration, and effectiveness. A cost-effectiveness analysis indicated that utilizing repeated discriminatory testing and the predictive model is an extremely beneficial screening approach for non-discriminatory reactive blood donors. Conclusion Nearly two-third (65.52%) of the non-discriminatory reactive blood donors were HBV-DNA positive. Our innovative approach of constructing a predictive model as a supplementary screening strategy, combined with repeated discriminatory experiments, can effectively identify the infection status of non-discriminatory reactive blood donors, thereby increasing the safety of blood transfusions.

Joint application of mathematic models in assessing the residual risk of hepatitis C virus transmitted through blood transfusion

Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study

A System Dynamics Modelling Simulation Based on a Cohort of Hepatitis B Epidemic Research in East China Community

Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta-analysis

The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China

The prevalence of Human Immunodeficiency Virus infection among voluntary blood donors in mainland China: A systematic review and meta-analysis

High Frequencies of Hgv and Ttv Infections in Blood Donors in Hangzhou

Quality Control Measures for Lowering the Seroconversion Rate of Hemodialysis Patients with Hepatitis B or C Virus.

Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China

Diverse Genotypes of Hepatitis C Virus in Voluntary Blood Donors in Shanghai, China

A Mathematical Model to Study the Potential Hepatitis B Virus Infections and Effects of Vaccination Strategies in China

The Development of A Combined Mathematical Model to Forecast the Incidence of Hepatitis E in Shanghai, China

Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study.

Prevalence, incidence, and residual risk for human immunodeficiency virus among blood donors from 2003 to 2022 in Guangzhou, China

A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation.

Epidemiologic study of HIV infection among voluntary blood donors in Zhejiang province from 2008 to 2010

Incidence and Estimated Rates of Residual Risk for HIV, Hepatitis C, Hepatitis B and Human T-cell Lymphotropic Viruses in Blood Donors in Canada, 1990-2000.

Residual risk and waste in donated blood with pooled nucleic acid testing

A Bayesian Meta-Analysis on Prevalence of Hepatitis B Virus Infection among Chinese Volunteer Blood Donors

Prevalence of Transfusion-Transmitted Infections in Hospitalized Patients Before Transfusion and Volunteer Blood Donors in Zhejiang Province, China.

[Retrospective Analysis of Blood Test Results of Volunteer Blood Donors]